The U.S. Department of Defense has announced a new routine screening for testosterone deficiency that will apply to all active‑duty and Reserve personnel aged 30 and older. Secretary of Defense Pete Hegseth outlined the plan in a video posted to X, stating that the goal is to ensure soldiers maintain optimal hormone levels for peak performance and for long‑term health after service.
Under the new protocol, low‑testosterone soldiers will be offered voluntary hormone replacement therapy. The Pentagon spokesperson said the initiative will establish a comprehensive baseline, allowing targeted treatment that can improve muscle strength, energy, mood and even bone density, with the aim of sustaining an able and decisive fighting force.
The policy echoes broader health reforms in the U.S. healthcare system, where officials have been pushing to maintain a safe and effective labeling of testosterone replacement products as well as to ease prescribing restrictions. While the Secretary emphasized that this program is not about artificial performance enhancement, it has already sparked debate among lawmakers – including veteran senators urging equal testing for women.
Medical experts highlight that, although testosterone screening can provide significant benefits, therapy should be used only when symptoms are present, to avoid potential side effects such as infertility and cardiovascular risk. Still, the wider military body believes that such proactive health measures reinforce long‑term resilience among troops, reducing the medical and logistical burden on defense infrastructure.
